Cargando…
Multiple Sulfatase Deficiency: A Disease Comprising Mucopolysaccharidosis, Sphingolipidosis, and More Caused by a Defect in Posttranslational Modification
Multiple sulfatase deficiency (MSD, MIM #272200) is an ultra-rare disease comprising pathophysiology and clinical features of mucopolysaccharidosis, sphingolipidosis and other sulfatase deficiencies. MSD is caused by impaired posttranslational activation of sulfatases through the formylglycine gener...
Autores principales: | Schlotawa, Lars, Adang, Laura A., Radhakrishnan, Karthikeyan, Ahrens-Nicklas, Rebecca C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279497/ https://www.ncbi.nlm.nih.gov/pubmed/32414121 http://dx.doi.org/10.3390/ijms21103448 |
Ejemplares similares
-
Natural history of multiple sulfatase deficiency: Retrospective phenotyping and functional variant analysis to characterize an ultra‐rare disease
por: Adang, Laura A., et al.
Publicado: (2020) -
Drug screening identifies tazarotene and bexarotene as therapeutic agents in multiple sulfatase deficiency
por: Schlotawa, Lars, et al.
Publicado: (2023) -
A homozygous missense variant of SUMF1 in the Bedouin population extends the clinical spectrum in ultrarare neonatal multiple sulfatase deficiency
por: Staretz‐Chacham, Orna, et al.
Publicado: (2020) -
Multiple Sulfatase Deficiency from an Ophthalmologist’s Perspective—Case Report and Literature Review
por: Schittkowski, Michael P., et al.
Publicado: (2023) -
Severe neonatal multiple sulfatase deficiency presenting with hydrops fetalis in a preterm birth patient
por: Schlotawa, Lars, et al.
Publicado: (2019)